Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease.

Castelnuovo G, Perez-Diaz-Del-Campo N, Guariglia M, Poggiolini I, Armandi A, Rosso C, Caviglia GP, Bugianesi E. Minerva Gastroenterol (Torino). 2023 Mar 9. doi: 10.23736/S2724-5985.23.03361-2.